TACT2, NCT00301925: Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery |
|
|
| Active, not recruiting | 3 | 4400 | Europe | pegfilgrastim, capecitabine, cyclophosphamide, epirubicin hydrochloride, fluorouracil, methotrexate, adjuvant therapy | Institute of Cancer Research, United Kingdom | Breast Cancer | 09/24 | 09/24 | | |
